ArticleJournal of cutaneous medicine and surgery
Emerging Uses of Artificial Intelligence in Chronic Dermatologic Disease: A Scoping Review.
Article in Journal of cutaneous medicine and surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRecent years have seen a surge in the use of artificial intelligence (AI) in healthcare, including dermatology. This scoping review aimed to assess the emerging applications of AI use in the context of chronic, non-neoplastic dermatologic diseases.
methodsMEDLINE, Embase, PubMed and SCOPUS were searched on August 11, 2023 using variations of the search concepts "dermatology," "artificial intelligence," and 12 common chronic dermatologic conditions. Article screening and data extraction were completed, and each study was categorized into themes and conditions.
resultsA total of 224 unique studies were included. The most prevalent conditions that were studied in the context of AI included psoriasis (n = 67), atopic dermatitis/eczema (n = 41) and acne (n = 36). The majority of AI applications involved clinical evaluation (n = 176), images (analysis, generation or segmentation) (n = 163) and data analysis (n = 46). Clinical evaluation was further divided into 2 subthemes: diagnosis (n = 104) and disease assessment (n = 67). Diagnostic and analytic applications of AI are limited by the training datasets available (quantity of training data, image quality) and insufficient diagnostic information provided (eg, the patient's reported history of their lesion, disease/symptom onset and risk factors).
conclusionsCommon applications of AI are predominantly as an automated diagnostic tool for evaluating disease severity/characteristics, while niche and novel applications were explored further. However, recognizing the limitations of technology is critical prior to the widespread application of AI in dermatological practice. The insights from the current study can inform clinical adoption of AI in dermatology, and highlight research gaps to guide future academic initiatives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.